CryoLife (Germany) Performance
| CYL Stock | EUR 31.90 0.40 1.24% |
The firm shows a Beta (market volatility) of 0.0924, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CryoLife's returns are expected to increase less than the market. However, during the bear market, the loss of holding CryoLife is expected to be smaller as well. At this point, CryoLife has a negative expected return of -0.31%. Please make sure to confirm CryoLife's rate of daily change, and the relationship between the skewness and day typical price , to decide if CryoLife performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CryoLife has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Last Split Factor 3:2 | Ex Dividend Date 2015-12-09 | Last Split Date 2000-12-28 |
1 | Artivion Misses Q4 CY2025 Sales Expectations - TradingView | 02/12/2026 |
CryoLife |
CryoLife Relative Risk vs. Return Landscape
If you would invest 3,950 in CryoLife on November 25, 2025 and sell it today you would lose (720.00) from holding CryoLife or give up 18.23% of portfolio value over 90 days. CryoLife is currently producing negative expected returns and takes up 2.0337% volatility of returns over 90 trading days. Put another way, 18% of traded stocks are less volatile than CryoLife, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CryoLife Target Price Odds to finish over Current Price
The tendency of CryoLife Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 31.90 | 90 days | 31.90 | about 97.0 |
Based on a normal probability distribution, the odds of CryoLife to move above the current price in 90 days from now is about 97.0 (This CryoLife probability density function shows the probability of CryoLife Stock to fall within a particular range of prices over 90 days) .
CryoLife Price Density |
| Price |
Predictive Modules for CryoLife
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CryoLife. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CryoLife Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CryoLife is not an exception. The market had few large corrections towards the CryoLife's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CryoLife, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CryoLife within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.27 | |
β | Beta against Dow Jones | 0.09 | |
σ | Overall volatility | 2.60 | |
Ir | Information ratio | -0.17 |
CryoLife Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CryoLife for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CryoLife can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CryoLife generated a negative expected return over the last 90 days | |
| CryoLife has high likelihood to experience some financial distress in the next 2 years | |
| CryoLife has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 388.54 M. Net Loss for the year was (13.36 M) with profit before overhead, payroll, taxes, and interest of 284.23 M. | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Artivion Misses Q4 CY2025 Sales Expectations - TradingView |
CryoLife Fundamentals Growth
CryoLife Stock prices reflect investors' perceptions of the future prospects and financial health of CryoLife, and CryoLife fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CryoLife Stock performance.
| Return On Equity | 0.027 | ||||
| Return On Asset | 0.0234 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 1.71 B | ||||
| Shares Outstanding | 47.84 M | ||||
| Price To Earning | 303.28 X | ||||
| Price To Book | 4.09 X | ||||
| Price To Sales | 3.50 X | ||||
| Revenue | 388.54 M | ||||
| Gross Profit | 284.23 M | ||||
| EBITDA | 53.8 M | ||||
| Net Income | (13.36 M) | ||||
| Cash And Equivalents | 40.26 M | ||||
| Cash Per Share | 1.08 X | ||||
| Total Debt | 195 K | ||||
| Debt To Equity | 98.30 % | ||||
| Book Value Per Share | 7.95 X | ||||
| Cash Flow From Operations | 22.24 M | ||||
| Earnings Per Share | 0.18 X | ||||
| Total Asset | 789.1 M | ||||
| Retained Earnings | (61.27 M) | ||||
About CryoLife Performance
By analyzing CryoLife's fundamental ratios, stakeholders can gain valuable insights into CryoLife's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CryoLife has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CryoLife has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people.Things to note about CryoLife performance evaluation
Checking the ongoing alerts about CryoLife for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CryoLife help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CryoLife generated a negative expected return over the last 90 days | |
| CryoLife has high likelihood to experience some financial distress in the next 2 years | |
| CryoLife has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 388.54 M. Net Loss for the year was (13.36 M) with profit before overhead, payroll, taxes, and interest of 284.23 M. | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Artivion Misses Q4 CY2025 Sales Expectations - TradingView |
- Analyzing CryoLife's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CryoLife's stock is overvalued or undervalued compared to its peers.
- Examining CryoLife's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CryoLife's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CryoLife's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CryoLife's stock. These opinions can provide insight into CryoLife's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CryoLife Stock analysis
When running CryoLife's price analysis, check to measure CryoLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoLife is operating at the current time. Most of CryoLife's value examination focuses on studying past and present price action to predict the probability of CryoLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoLife's price. Additionally, you may evaluate how the addition of CryoLife to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |